Gradient Capital Advisors’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$854K Buy
2,856
+137
+5% +$38.1K 0.2% 85
2026
Q1
$741K Sell
2,719
-37
-1% -$10.6K 0.19% 86
2025
Q4
$793K Buy
2,756
+68
+3% +$19K 0.2% 83
2025
Q3
$698K Sell
2,688
-107
-4% -$26.8K 0.19% 86
2025
Q2
$694K Sell
2,795
-234
-8% -$57.8K 0.21% 83
2025
Q1
$802K Sell
3,029
-136
-4% -$36.2K 0.26% 74
2024
Q4
$803K Sell
3,165
-59
-2% -$15.9K 0.26% 70
2024
Q3
$910K Buy
3,224
+6
+0.2% +$1.67K 0.3% 67
2024
Q2
$856K Sell
3,218
-182
-5% -$47.7K 0.31% 68
2024
Q1
$920K Sell
3,400
-87
-2% -$22.9K 0.34% 64
2023
Q4
$874K Sell
3,487
-30
-0.9% -$7.11K 0.33% 68
2023
Q3
$827K Buy
3,517
+7
+0.2% +$1.71K 0.35% 64
2023
Q2
$859K Buy
3,510
+60
+2% +$14.6K 0.34% 64
2023
Q1
$823K Buy
3,450
+15
+0.4% +$3.61K 0.35% 65
2022
Q4
$852K Buy
3,435
+28
+0.8% +$6.79K 0.39% 61
2022
Q3
$762K Buy
3,407
+416
+14% +$99.3K 0.36% 65
2022
Q2
$704K Buy
2,991
+94
+3% +$22.7K 0.34% 65
2022
Q1
$737K Buy
2,897
+5
+0.2% +$1.24K 0.31% 65
2021
Q4
$771K Buy
2,892
+11
+0.4% +$2.81K 0.32% 66
2021
Q3
$712K Buy
2,881
+40
+1% +$10.3K 0.33% 66
2021
Q2
$702K Sell
2,841
-94
-3% -$22.5K 0.33% 66
2021
Q1
$671K Hold
2,935
0.36% 62
2020
Q4
$657K Buy
2,935
+143
+5% +$30.6K 0.37% 59
2020
Q3
$569K Buy
2,792
+535
+24% +$108K 0.36% 60
2020
Q2
$435K Buy
2,257
+114
+5% +$21.4K 0.29% 67
2020
Q1
$356K Sell
2,143
-51
-2% -$9.32K 0.29% 69
2019
Q4
$421K Sell
2,194
-72
-3% -$12.9K 0.29% 69
2019
Q3
$380K Sell
2,266
-30
-1% -$5.13K 0.28% 69
2019
Q2
$399K Sell
2,296
-73
-3% -$12.3K 0.31% 63
2019
Q1
$409K Buy
2,369
+14
+0.6% +$2.37K 0.33% 58
2018
Q4
$378K Buy
2,355
+9
+0.4% +$1.52K 0.33% 57
2018
Q3
$423K Buy
2,346
+15
+0.6% +$2.58K 0.36% 57
2018
Q2
$371K Hold
2,331
0.34% 59
2018
Q1
$358K Buy
2,331
+69
+3% +$11K 0.36% 54
2017
Q4
$349K Buy
+2,262
New +$347K 0.36% 54

Other funds holding VHT

Gradient Capital Advisors's VHT Position: Q2 2026 in Review

Gradient Capital Advisors increased its Vanguard Health Care ETF (VHT) stake by 5% in Q2 2026, buying an estimated $38.1K and bringing the position to 2,856 shares worth $854K. The position accounts for 0.2% of the portfolio, ranked #85.

Gradient Capital Advisors first reported a position in VHT in Q4 2017 and has held it in 35 quarters since. The position peaked at $920K in Q1 2024. 180 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Gradient Capital Advisors held 2,856 shares of Vanguard Health Care ETF worth $854K as of Q2 2026.
  • Gradient Capital Advisors bought 137 Vanguard Health Care ETF shares in Q2 2026, an estimated $38.1K.
  • Vanguard Health Care ETF made up 0.2% of Gradient Capital Advisors's portfolio in Q2 2026, its #85 holding.
  • Gradient Capital Advisors first reported a position in Vanguard Health Care ETF in Q4 2017 and has held it in 35 quarters since.
  • Gradient Capital Advisors's Vanguard Health Care ETF position peaked at $920K in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Gradient Capital Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.